Riding the CSL highs

Last week I suggested buying CSL Limited (CSL) in a bid to take advantage of the strong price momentum.

Source: Bloomberg

The stock has continued to trade at fresh 52-week highs and has now nudged through the $85 mark. CSL is racing towards $86 after trading at a high of $85.91 today. This has seen the price up 6.8% from the entry level and while it is tempting to take profits now, I would suggest riding the trend until it is exhausted. Although the stock is quite overbought with an RSI of 77.84, momentum indicators are still quite bullish. I feel trailing stops from $77.50 to $82.50 is the best way to proceed, as it leaves a bit of room for the stock to move. I will continue to monitor the stock’s progress and will update it in due course.

Click to enlarge

IGA, may distribute information/research produced by its respective foreign affiliates within the IG Group of companies pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the research is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, IGA accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact IGA at 6390 5118 for matters arising from, or in connection with the information distributed.

This information/research prepared by IGA or IGA Group is intended for general circulation. It does not take into account the specific investment objectives, financial situation or particular needs of any particular person. You should take into account your specific investment objectives, financial situation or particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. In addition to the disclaimer above, the information does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. Any views and opinions expressed may be changed without an update.

See important Research Disclaimer.